#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA653338	F	Cytotoxicity against CAOV-3 human tumor cell lines	Homo sapiens	15	ALA1129725	cell-based format	Scientific Literature
2.	ALA653339	F	In vitro cytotoxicity against CAOV-3 human tumor cell line.	Homo sapiens	17	ALA1151007	cell-based format	Scientific Literature
3.	ALA653340	F	Compound was evaluated for in vitro antiproliferative activity against CAOV-3 human ovarian cancer cell line	Homo sapiens	10	ALA1130880	cell-based format	Scientific Literature
4.	ALA653341	F	In vitro cytotoxicity against human tumor cell line CAOV-3	Homo sapiens	17	ALA1131880	cell-based format	Scientific Literature
5.	ALA657427	F	Compound was tested for cytotoxicity against CaOv3 human solid tumor cell line	Homo sapiens	2	ALA1134739	cell-based format	Scientific Literature
6.	ALA657428	F	Compound was tested for cytotoxicity against CaOv3 human solid tumor cell line	Homo sapiens	1	ALA1134739	cell-based format	Scientific Literature
7.	ALA657429	F	Compound was tested for cytotoxicity against CaOv3 human solid tumor cell line; NA=Not active	Homo sapiens	2	ALA1134739	cell-based format	Scientific Literature
8.	ALA653700	F	Percent of growth inhibition of Cell line Caov-3(Ovarian) by the compound	Homo sapiens	3	ALA1132376	cell-based format	Scientific Literature
9.	ALA653701	F	Percent of growth inhibition of Cell line Caov-3(Ovarian) by the compound	Homo sapiens	2	ALA1132376	cell-based format	Scientific Literature
10.	ALA653702	F	Efficacy is growth inhibition activity at 10 uM concentration relative to the maximum activity observed for 4-HPR with Caov-3 cell line		9	ALA1148290	cell-based format	Scientific Literature
11.	ALA653703	F	Potency of compound was determined from ability to inhibit the growth of ovarian carcinoma cell line Caov-3		9	ALA1148290	cell-based format	Scientific Literature
12.	ALA2363161	F	SANGER: Inhibition of human Caov-3 cell growth in a cell viability assay.	Homo sapiens	38	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
13.	ALA4012917	F	Growth inhibition of human Caov3 cells after 6 days in presence of 1% FBS by Cell-Titer Glo assay	Homo sapiens	1	ALA4011625	cell-based format	Scientific Literature
14.	ALA4012944	F	Growth inhibition of human Caov3 cells at 10 uM after 6 days in presence of 1% FBS by Cell-Titer Glo assay relative to control	Homo sapiens	1	ALA4011625	cell-based format	Scientific Literature
15.	ALA4012955	F	Growth inhibition of human Caov3 cells after 6 days in presence of 10% FBS by Cell-Titer Glo assay	Homo sapiens	1	ALA4011625	cell-based format	Scientific Literature
16.	ALA4012995	F	Growth inhibition of human Caov3 cells at 10 uM after 6 days in presence of 10% FBS by Cell-Titer Glo assay relative to control	Homo sapiens	1	ALA4011625	cell-based format	Scientific Literature
17.	ALA4037479	F	Antiproliferative activity against human Caov3 cells after 96 hrs	Homo sapiens	2	ALA4033784	cell-based format	Scientific Literature
18.	ALA4261717	F	Cytotoxicity against human Caov3 cells assessed as decrease in cell viability after 72 hrs by CCK8 assay	Homo sapiens	1	ALA4261482	cell-based format	Scientific Literature
19.	ALA4275267	F	Antiproliferative activity against human Caov3 cells measured after 96 hrs	Homo sapiens	3	ALA4270621	cell-based format	Scientific Literature
20.	ALA4343280	F	Antiproliferative activity against human Caov3 cells by SRB assay	Homo sapiens	1	ALA4342418	cell-based format	Scientific Literature